Literature DB >> 22460343

Iron deposition on SWI-filtered phase in the subcortical deep gray matter of patients with clinically isolated syndrome may precede structure-specific atrophy.

J Hagemeier1, B Weinstock-Guttman, N Bergsland, M Heininen-Brown, E Carl, C Kennedy, C Magnano, D Hojnacki, M G Dwyer, R Zivadinov.   

Abstract

BACKGROUND AND
PURPOSE: Increasing evidence suggests that iron deposition is present in the later stages of MS. In this study we examined abnormal phase values, indicative of increased iron content on SWI-filtered phase images of the SDGM in CIS patients and HC. We also examined the association of abnormal phase with conventional MR imaging outcomes at first clinical onset.
MATERIALS AND METHODS: Forty-two patients with CIS (31 female, 11 male) and 65 age and sex-matched HC (41 female, 24 male) were scanned on a 3T scanner. Mean age was 40.1 (SD = 10.4) years in patients with CIS, and 42.8 (SD = 14) years in HC, while mean disease duration was 1.2 years (SD = 1.3) in patients with CIS. MP-APT, NPTV, and normalized volume measurements were derived for all SDGM structures. Parametric and nonparametric group-wise comparisons were performed, and associations were determined with other MR imaging metrics.
RESULTS: Patients with CIS had significantly increased MP-APT (P = .029) and MP-APT volume (P = .045) in the pulvinar nucleus of the thalamus compared with HC. Furthermore, the putamen (P = .004), caudate (P = .035), and total SDGM (P = .048) displayed significant increases in MP-APT volume, while MP-APT was also significantly increased in the putamen (P = .029). No global or regional volumetric MR imaging differences were found between the study groups. Significant correlations were observed between increased MP-APT volumes of total SDGM, caudate, thalamus, hippocampus, and substantia nigra with white matter atrophy and increased T2 lesion volume (P < .05).
CONCLUSION: Patients with CIS showed significantly increased content and volume of iron, as determined by abnormal SWI-phase measurement, in the various SDGM structures, suggesting that iron deposition may precede structure-specific atrophy.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22460343      PMCID: PMC7966566          DOI: 10.3174/ajnr.A3030

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  53 in total

1.  Prediction of longitudinal brain atrophy in multiple sclerosis by gray matter magnetic resonance imaging T2 hypointensity.

Authors:  Robert A Bermel; Srinivas R Puli; Richard A Rudick; Bianca Weinstock-Guttman; Elizabeth Fisher; Frederick E Munschauer; Rohit Bakshi
Journal:  Arch Neurol       Date:  2005-09

2.  Deep grey matter T2 hypo-intensity in patients with paediatric multiple sclerosis.

Authors:  Antonia Ceccarelli; Maria A Rocca; Elisabetta Perego; Lucia Moiola; Angelo Ghezzi; Vittorio Martinelli; Giancarlo Comi; Massimo Filippi
Journal:  Mult Scler       Date:  2011-01-12       Impact factor: 6.312

3.  The predictive value of gray matter atrophy in clinically isolated syndromes.

Authors:  M Calabrese; F Rinaldi; I Mattisi; V Bernardi; A Favaretto; P Perini; P Gallo
Journal:  Neurology       Date:  2011-05-25       Impact factor: 9.910

4.  Onset and underpinnings of white matter atrophy at the very early stage of multiple sclerosis--a two-year longitudinal MRI/MRSI study of corpus callosum.

Authors:  B Audoin; D Ibarrola; I Malikova; E Soulier; S Confort-Gouny; M V Au Duong; F Reuter; P Viout; A Ali-Chérif; P J Cozzone; J Pelletier; J P Ranjeva
Journal:  Mult Scler       Date:  2007-01       Impact factor: 6.312

5.  Brain iron detected by SWI high pass filtered phase calibrated with synchrotron X-ray fluorescence.

Authors:  Karla Hopp; Bogdan F Gh Popescu; Richard P E McCrea; Sheri L Harder; Christopher A Robinson; Mark E Haacke; Ali H Rajput; Alex Rajput; Helen Nichol
Journal:  J Magn Reson Imaging       Date:  2010-06       Impact factor: 4.813

Review 6.  Iron in chronic brain disorders: imaging and neurotherapeutic implications.

Authors:  James Stankiewicz; S Scott Panter; Mohit Neema; Ashish Arora; Courtney E Batt; Rohit Bakshi
Journal:  Neurotherapeutics       Date:  2007-07       Impact factor: 7.620

Review 7.  Iron, the substantia nigra and related neurological disorders.

Authors:  Amanda M Snyder; James R Connor
Journal:  Biochim Biophys Acta       Date:  2008-08-20

8.  Quantitative assessment of brain iron by R(2)* relaxometry in patients with clinically isolated syndrome and relapsing-remitting multiple sclerosis.

Authors:  M Khalil; C Enzinger; C Langkammer; M Tscherner; M Wallner-Blazek; M Jehna; S Ropele; S Fuchs; F Fazekas
Journal:  Mult Scler       Date:  2009-06-25       Impact factor: 6.312

9.  Determinants of brain iron in multiple sclerosis: a quantitative 3T MRI study.

Authors:  M Khalil; C Langkammer; S Ropele; K Petrovic; M Wallner-Blazek; M Loitfelder; M Jehna; G Bachmaier; R Schmidt; C Enzinger; S Fuchs; F Fazekas
Journal:  Neurology       Date:  2011-10-05       Impact factor: 9.910

10.  Iron and neurodegeneration in multiple sclerosis.

Authors:  Michael Khalil; Charlotte Teunissen; Christian Langkammer
Journal:  Mult Scler Int       Date:  2011-02-10
View more
  23 in total

1.  Heterogeneity of Cortical Lesion Susceptibility Mapping in Multiple Sclerosis.

Authors:  M Castellaro; R Magliozzi; A Palombit; M Pitteri; E Silvestri; V Camera; S Montemezzi; F B Pizzini; A Bertoldo; R Reynolds; S Monaco; M Calabrese
Journal:  AJNR Am J Neuroradiol       Date:  2017-04-13       Impact factor: 3.825

2.  Targeting Iron Dyshomeostasis for Treatment of Neurodegenerative Disorders.

Authors:  Niels Bergsland; Eleonora Tavazzi; Ferdinand Schweser; Dejan Jakimovski; Jesper Hagemeier; Michael G Dwyer; Robert Zivadinov
Journal:  CNS Drugs       Date:  2019-11       Impact factor: 5.749

3.  Increased brain iron deposition is a risk factor for brain atrophy in patients with haemodialysis: a combined study of quantitative susceptibility mapping and whole brain volume analysis.

Authors:  Chao Chai; Mengjie Zhang; Miaomiao Long; Zhiqiang Chu; Tong Wang; Lijun Wang; Yu Guo; Shuo Yan; E Mark Haacke; Wen Shen; Shuang Xia
Journal:  Metab Brain Dis       Date:  2015-03-22       Impact factor: 3.584

4.  Quantitative susceptibility mapping in multiple sclerosis.

Authors:  Christian Langkammer; Tian Liu; Michael Khalil; Christian Enzinger; Margit Jehna; Siegrid Fuchs; Franz Fazekas; Yi Wang; Stefan Ropele
Journal:  Radiology       Date:  2013-01-11       Impact factor: 11.105

5.  Hemoglobin as a source of iron overload in multiple sclerosis: does multiple sclerosis share risk factors with vascular disorders?

Authors:  Vladimir V Bamm; George Harauz
Journal:  Cell Mol Life Sci       Date:  2014-02-07       Impact factor: 9.261

6.  Early silent microstructural degeneration and atrophy of the thalamocortical network in multiple sclerosis.

Authors:  Michael Deppe; Julia Krämer; Jan-Gerd Tenberge; Jasmin Marinell; Wolfram Schwindt; Katja Deppe; Sergiu Groppa; Heinz Wiendl; Sven G Meuth
Journal:  Hum Brain Mapp       Date:  2016-02-27       Impact factor: 5.038

Review 7.  The thalamus and multiple sclerosis: modern views on pathologic, imaging, and clinical aspects.

Authors:  Alireza Minagar; Michael H Barnett; Ralph H B Benedict; Daniel Pelletier; Istvan Pirko; Mohamad Ali Sahraian; Elliott Frohman; Robert Zivadinov
Journal:  Neurology       Date:  2013-01-08       Impact factor: 9.910

8.  Mapping of thalamic magnetic susceptibility in multiple sclerosis indicates decreasing iron with disease duration: A proposed mechanistic relationship between inflammation and oligodendrocyte vitality.

Authors:  Ferdinand Schweser; Ana Luiza Raffaini Duarte Martins; Jesper Hagemeier; Fuchun Lin; Jannis Hanspach; Bianca Weinstock-Guttman; Simon Hametner; Niels Bergsland; Michael G Dwyer; Robert Zivadinov
Journal:  Neuroimage       Date:  2017-10-31       Impact factor: 6.556

9.  Quantitative Susceptibility Mapping of the Thalamus: Relationships with Thalamic Volume, Total Gray Matter Volume, and T2 Lesion Burden.

Authors:  G C Chiang; J Hu; E Morris; Y Wang; S A Gauthier
Journal:  AJNR Am J Neuroradiol       Date:  2018-01-25       Impact factor: 3.825

Review 10.  Visualizing iron in multiple sclerosis.

Authors:  Francesca Bagnato; Simon Hametner; Edward Brian Welch
Journal:  Magn Reson Imaging       Date:  2013-01-22       Impact factor: 2.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.